Andrea J. Allen

Andrea J. Allen

Auto-generated profile, based on publicly available information

Andrea J. Allen

Vermont Complex Systems Center, University of Vermont, Burlington, Vermont 05405, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2022 in Physical Review Research
Verified
Journal Article
Open access
PDF file
AAAndrea J. Allen
Andrea J. Allen
MBMariah C. Boudreau
Mariah C. Boudreau
NRNicholas J. Roberts
Nicholas J. Roberts
AAAntoine Allard
Antoine Allard
LHLaurent Hébert-Dufresne
Laurent Hébert-Dufresne
The interplay of biological, social, structural, and random factors makes disease forecasting extraordinarily complex. The course of an epidemic exhibits average growth dynamics determined by features of the pathogen and the population, yet also features significant variability reflecting the stochastic nature of disease spread. In this paper, we reframe a stochastic branching process analysis in terms of probability generating functions and compare it to continuous time epidemic simulations on networks. In doing so, we predict the diversity of emerging epidemic courses on both homogeneous and heterogeneous networks. We show how the challenge of inferring the early course of an epidemic falls on the randomness of disease spread more so than on the heterogeneity of contact patterns. We provide an analysis, which helps quantify, in real time, the probability that an epidemic goes supercritical or conversely, dies stochastically. These probabilities are often assumed to be one and zero, respectively, if the basic reproduction number or R0 is greater than 1, ignoring the heterogeneity and randomness inherent to disease spread. This framework can give more insight into early epidemic spread by weighting standard deterministic models with likelihood to inform pandemic preparedness with probabilistic forecasts.

26 April 2024 in Research Square
Verified
Preprint
Open access
PDF file
HMHannah Mandel
Hannah Mandel
YYYun Yoo
Yun Yoo
AAAndrea Allen
Andrea Allen
SASajjad Abedian
Sajjad Abedian
ZVZoe Verzani
Zoe Verzani
RMRichard Moffitt
Richard Moffitt
Estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) incidence, also known as Long COVID, have varied across studies and changed over time. We estimated PASC incidence among adult and pediatric populations in three nationwide research networks of electronic health records (EHR) participating in the RECOVER Initiative using different classification algorithms (computable phenotypes). Overall, 7% of children and 8.5%-26.4% of adults developed PASC, depending on computable phenotype used. Excess incidence among SARS-CoV-2 patients was 4% in children and ranged from 4-7% among adults, representing a lower-bound incidence estimation based on two control groups - contemporary COVID-19 negative and historical patients (2019). Temporal patterns were consistent across networks, with peaks associated with introduction of new viral variants. Our findings indicate that preventing and mitigating Long COVID remains a public health priority. Examining temporal patterns and risk factors of PASC incidence informs our understanding of etiology and can improve prevention and management.

15 February 2024 in Physical Review Letters
Verified
Journal Article
Closed access
PDF file
AAAndrea J. Allen
Andrea J. Allen
CMCristopher Moore
Cristopher Moore
LHLaurent Hébert-Dufresne
Laurent Hébert-Dufresne
Studies of dynamics on temporal networks often represent the network as a series of “snapshots,” static networks active for short durations of time. We argue that successive snapshots can be aggregated if doing so has little effect on the overlying dynamics. We propose a method to compress network chronologies by progressively combining pairs of snapshots whose matrix commutators have the smallest dynamical effect. We apply this method to epidemic modeling on real contact tracing data and find that it allows for significant compression while remaining faithful to the epidemic dynamics.

26 December 2022 in medRxiv
Verified
Preprint
Open access
PDF file
VLVitaly Lorman
Vitaly Lorman
HRHanieh Razzaghi
Hanieh Razzaghi
XSXing Song
Xing Song
KMKeith Morse
Keith Morse
LULevon Utidjian
Levon Utidjian
LBL. Charles Bailey
L. Charles Bailey
Background As clinical understanding of pediatric Post-Acute Sequelae of SARS CoV-2 (PASC) develops, and hence the clinical definition evolves, it is desirable to have a method to reliably identify patients who are likely to have post-acute sequelae of SARS CoV-2 (PASC) in health systems data. Methods and Findings In this study, we developed and validated a machine learning algorithm to classify which patients have PASC (distinguishing between Multisystem Inflammatory Syndrome in Children (MIS-C) and non-MIS-C variants) from a cohort of patients with positive SARS-CoV-2 test results in pediatric health systems within the PEDSnet EHR network. Patient features included in the model were selected from conditions, procedures, performance of diagnostic testing, and medications using a tree-based scan statistic approach. We used an XGboost model, with hyperparameters selected through cross-validated grid search, and model performance was assessed using 5-fold cross-validation. Model predictions and feature importance were evaluated using Shapley Additive exPlanation (SHAP) values. Conclusions The model provides a tool for identifying patients with PASC and an approach to characterizing PASC using diagnosis, medication, laboratory, and procedure features in health systems data. Using appropriate threshold settings, the model can be used to identify PASC patients in health systems data at higher precision for inclusion in studies or at higher recall in screening for clinical trials, especially in settings where PASC diagnosis codes are used less frequently or less reliably. Analysis of how specific features contribute to the classification process may assist in gaining a better understanding of features that are associated with PASC diagnoses. Funding Source This research was funded by the National Institutes of Health (NIH) Agreement OT2HL161847-01 as part of the Researching COVID to Enhance Recovery (RECOVER) program of research. Disclaimer The content is solely the responsibility of the authors and does not necessarily represent the official views of the RECOVER Program, the NIH or other funders.